An empirical workflow for genome-wide single nucleotide polymorphism-based predictive modeling

por Floudas, Charalampos S., Balasubramanian, Jeya Balaji, Romkes, Marjorie, Gopalakrishnan, Vanathi
Publicado 2013

Matching Patients to Clinical Trials with Large Language Models

por Jin, Qiao, Wang, Zifeng, Floudas, Charalampos S., Sun, Jimeng, Lu, Zhiyong
Publicado 2023

Identifying genetic interactions associated with late-onset Alzheimer’s disease

por Floudas, Charalampos S, Um, Nara, Kamboh, M Ilyas, Barmada, Michael M, Visweswaran, Shyam
Publicado 2014

Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy

por Kumar, Vivek, Chaudhary, Neha, Garg, Mohit, Floudas, Charalampos S., Soni, Parita, Chandra, Abhinav B.
Publicado 2017

Corrigendum: Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy

por Kumar, Vivek, Chaudhary, Neha, Garg, Mohit, Floudas, Charalampos S., Soni, Parita, Chandra, Abhinav B.
Publicado 2017

Applications of large language models in cancer care: current evidence and future perspectives

por Iannantuono, Giovanni Maria, Bracken-Clarke, Dara, Floudas, Charalampos S., Roselli, Mario, Gulley, James L., Karzai, Fatima
Publicado 2023

Spatial Transcriptomic Analysis of Pituitary Corticotroph Tumors Unveils Intratumor Heterogeneity

por Piña, Jeremie Oliver, Faucz, Fabio R., Padilla, Cameron, Floudas, Charalampos S., Chittiboina, Prashant, Quezado, Martha, Tatsi, Christina
Publicado 2023

The genomics and epigenetics of olfactory neuroblastoma: A systematic review

por Kaur, Raman Preet, Izumchenko, Evgeny, Blakaj, Dukagjin M., Mladkova, Nikol, Lechner, Matt, Beaumont, Thomas L., Floudas, Charalampos S., Gallia, Gary L., London, Nyall R.
Publicado 2021

Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden

por Florou, Vaia, Floudas, Charalampos S, Maoz, Asaf, Naqash, Abdul Rafeh, Norton, Carter, Tan, Aik Choon, Sokol, Ethan S, Frampton, Garrett, Soares, Heloisa P, Puri, Sonam, Swami, Umang, Wilky, Breelyn, Hosein, Peter, Trent, Jonathan, Lopes, Gilberto de Lima, Park, Wungki, Garrido-Laguna, Ignacio
Publicado 2023

Phase I study of a multitargeted recombinant Ad5 PSA/MUC-1/brachyury-based immunotherapy vaccine in patients with metastatic castration-resistant prostate cancer (mCRPC)

por Bilusic, Marijo, McMahon, Sheri, Madan, Ravi A, Karzai, Fatima, Tsai, Yo-Ting, Donahue, Renee N, Palena, Claudia, Jochems, Caroline, Marté, Jennifer L, Floudas, Charalampos, Strauss, Julius, Redman, Jason, Abdul Sater, Houssein, Rabizadeh, Shahrooz, Soon-Shiong, Patrick, Schlom, Jeffrey, Gulley, James L
Publicado 2021

Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer

por DeMaria, Peter J, Lee-Wisdom, Katherine, Donahue, Renee N, Madan, Ravi A, Karzai, Fatima, Schwab, Angie, Palena, Claudia, Jochems, Caroline, Floudas, Charalampos, Strauss, Julius, Marté, Jennifer L, Redman, Jason Mark, Dombi, Eva, Widemann, Brigitte, Korchin, Borys, Adams, Tatiana, Pico-Navarro, Cesar, Heery, Christopher, Schlom, Jeffrey, Gulley, James L, Bilusic, Marijo
Publicado 2021